Results 191 to 200 of about 27,956 (253)

PROTOCOL: Comparative Effectiveness of Tools for Communicating Health Research Results to Study Participants and Others With Relevant Lived Experience: A Living Systematic Review of Randomized Controlled Trials. [PDF]

Campbell Syst Rev
Nassar EL, Adams CE, Rice DB, Wurz A, South A, Boruff J, Golberg M, Carrier ME, Bartlett SJ, Gillies K, Kocher A, Kwakkenbos L, Ndosi M, Sydes MR, Benedetti A, Thombs BD, SPIN Patient Engagement Advisory Team.   +16 more
europepmc   +1 more source

Evaluating context effects on PHQ-8 somatic item scores among people with a chronic medical condition: a scleroderma patient-centred intervention network randomised experiment. [PDF]

Epidemiol Psychiatr Sci
Hu S, Carrier ME, Golberg M, Geoffroy MC, Kwakkenbos L, Bartlett SJ, Fortuné C, Gietzen A, Gottesman K, Lawrie-Jones A, Malcarne VL, Richard M, Sauvé M, Mouthon L, Benedetti A, Thombs BD, SPIN Investigators.   +16 more
europepmc   +1 more source

Clinical characteristics, autoantibody profiles, and therapeutic outcomes of juvenile systemic sclerosis: an 11-year single-center experience from China. [PDF]

Front Immunol
Wang Y, Tang W, Zhang Y, Zhang Z, An Y, Tang X.   +5 more
europepmc   +1 more source

Clinical and psychosocial determinants of oral handicap in systemic sclerosis: a cross-sectional study. [PDF]

Rheumatol Int
Erdoğan Soysal M, Turk I, Özdoğan Bircan A, Soysal M.   +3 more
europepmc   +1 more source

Scleroderma renal crisis: avoiding the diagnostic pitfalls of an elusive condition. [PDF]

Rheumatol Adv Pract
Ng IKS, Tang MS, See FH, Cho J.
europepmc   +1 more source

PD-1 inhibitor-induced systemic sclerosis with early interstitial lung disease and autoimmune thyroiditis in advanced gastric cancer: a case report and literature review. [PDF]

Front Oncol
Lyu Q, Xu X, She W, Wang J, Aimurula M, Zhou M, Ding J, Gu Y.   +7 more
europepmc   +1 more source

Immune checkpoint inhibitor-associated scleroderma refractory to corticosteroids: Clinical improvement with intravenous immune globulin and dupilumab. [PDF]

JAAD Case Rep
Abul-Enin DG, Edmonds NL, Rusu CA.
europepmc   +1 more source

Esomeprazole inhibits proliferation of scleroderma fibroblasts via cell cycle regulation. [PDF]

Front Pharmacol
Khan MA, Koniyan S, Ahir M, Jegga AG, Mayes MD, Gius D, Leung J, Bonnen MD, Montesi SB, Ghebre YT.   +9 more
europepmc   +1 more source

Anxiety symptoms and associated factors in the Scleroderma Patient-centered Intervention Network (SPIN) cohort: a cross-sectional study. [PDF]

Rheumatology (Oxford)
Provencher S, Carrier ME, Virgili-Gervais G, Golberg M, Henry RS, Kwakkenbos L, Fortuné C, Gietzen A, Gottesman K, Guillot G, Lawrie-Jones A, Sauvé M, Bartlett SJ, Hummers LK, Malcarne V, Mayes MD, Richard M, Stempel J, Wojeck RK, Mouthon L, Benedetti A, Thombs BD, Scleroderma Patient-centered Intervention Network Investigators.   +22 more
europepmc   +1 more source

Scleroderma Renal Crisis in a Patient with Limited Systemic Sclerosis [PDF]

, 2019
Alam, Usman, Celedon, Manuel A., Basrai, Zahir   +2 more
openaire